Web Research
Web Research
The web adds one decisive fact the filings alone do not emphasize enough: the market is already debating whether the Q4 2025 recovery was a head fake. Q1 2026 turned the question from "is Daqo low cost?" to "can Daqo sell product at economic prices?"
The Bottom Line from the Web
The most important web finding is the gap between external target-price optimism and the fresh Q1 operating miss. Analyst-target pages still show upside from $19, but recent earnings coverage centered on a revenue collapse, wider loss, and a Sell downgrade.
What Matters Most
The web evidence does not overturn the balance-sheet bull case. It narrows the burden of proof to one issue: Q2/Q3 sales volume must show that customers are buying, not just that Daqo can produce.
Recent News Timeline
What the Specialists Asked
The ultralight run skipped Dan's second-pass specialist-query web research, so this table synthesizes the staged phase-one research plus the queries raised by the completed specialists. Evidence is strongest on Q1 results, analyst targets, governance identities, and cost-curve narrative; it is thinner on real-time customer purchasing behavior.
Insider Spotlight
No staged web evidence showed recent insider buying or selling that changes the case. The meaningful insider signal is ownership concentration.
Industry Context
The industry context is unusually important because company-level execution is secondary to polysilicon market discipline. Web research repeatedly surfaced anti-involution policy, below-cost selling restrictions, and producer curtailments as the mechanism that could turn Daqo's balance sheet into earnings power. The risk is that policy improves quoted prices while real transactions remain thin.